Ovarian cancer clues hidden in blood and tissue
NCT ID NCT03419689
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects blood, tumor tissue, and other fluids from people with advanced ovarian cancer to find biological markers (biomarkers). Researchers will analyze these samples to understand why some patients live longer or respond better to treatment. Results may be shared with doctors to help guide future care decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GYNECOLOGIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Juravinski Cancer Centre
ACTIVE_NOT_RECRUITINGHamilton, Ontario, L8V 5C2, Canada
-
Kingston Health Sciences Centre
RECRUITINGKingston, Ontario, K7L 2V7, Canada
-
London Health Sciences Centre
RECRUITINGLondon, Ontario, Canada
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 1Z5, Canada
-
Royal Victoria Regional Health Centre
RECRUITINGBarrie, Ontario, L4M 6M2, Canada
-
Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, M4N 3M5, Canada
-
The Ottawa Hospital Cancer Centre
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized exercise program boost recovery in cancer survivors?
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- Can a targeted drug boost standard ovarian cancer therapy?
- Can a daily pill keep BRCA-Linked ovarian cancer at bay?
- New oral drug targets Cancer's growth engine in advanced tumours
- Braids and conditioner may boost scalp cooling against chemo hair loss